Core Viewpoint - Neumora Therapeutics, Inc. is facing a class action lawsuit due to allegations of issuing misleading statements regarding its clinical trials and the efficacy of its flagship therapeutic candidate, Navacaprant [4]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of all individuals or entities who purchased Neumora common stock during the class period starting on or about September 15, 2023 [3]. - The deadline for shareholders to register for the class action is April 7, 2025, and they are encouraged to register to monitor the case's progress [5]. Group 2: Allegations Against Neumora - The complaint alleges that Neumora amended the original Phase Two trial inclusion criteria to include patients with moderate to severe Major Depressive Disorder (MDD) to justify its Phase Three Program [4]. - It is claimed that the Phase Two Trials lacked adequate data regarding patient population size and gender ratio, which could affect the predictability of the KOASTAL-1 study results [4]. Group 3: Legal Representation - The Gross Law Firm, a nationally recognized class action law firm, is representing the shareholders and aims to protect investors' rights against deceit and fraud [6]. - The firm emphasizes its commitment to ensuring responsible business practices and seeks recovery for investors who suffered losses due to misleading statements by companies [6].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of TELUS International (Cda) Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's AI Data Solutions and its impact on profitability [1][3]. Summary by Relevant Sections Class Action Details - The class period for the lawsuit is from February 16, 2023, to August 1, 2024 [3]. - Shareholders who purchased shares during this period are encouraged to contact the firm for potential lead plaintiff appointment [1][4]. Allegations Against TELUS International - The complaint alleges that TELUS International's AI Data Solutions required the cannibalization of its higher-margin offerings [3]. - It is claimed that the company's declining profitability is linked to its push to develop AI capabilities [3]. - The shift towards AI is said to have put greater pressure on the company's margins than previously disclosed [3]. - As a result, the positive statements made by the defendants regarding the company's business and prospects were materially misleading [3]. Next Steps for Shareholders - Shareholders must register by March 31, 2025, to participate in the class action [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software [4]. Firm's Mission - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Sana Biotechnology, Inc. regarding a class action lawsuit due to alleged misleading statements and financial misrepresentations during a specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from March 17, 2023, to November 4, 2024 [3]. - Allegations include that Sana was at significant risk of insufficient funds to maintain operations and advance product candidates [3]. - Specific product candidates, SC291 in oncology, SC379, and SG299, were claimed to be less promising than represented [3]. - To preserve cash, Sana was likely to decrease funding for certain product candidates and significantly reduce its workforce [3]. - The defendants allegedly overstated Sana's financial capacity, leading to materially false and misleading public statements [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by May 20, 2025, to participate in potential recovery [4]. - Registration includes enrollment in a portfolio monitoring software for status updates throughout the case [4]. Firm's Commitment - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [5].

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Fluence's relationship with its founders and largest sources of revenue, Siemens AG and The AES Corporation, was poised to decline; (2) Siemens Energy, Siemens AG's U.S. affiliate, had accused the Company of engineering failures and fraud; (3) Fluence's margins and revenue growth were inflated as Siemens and AES were moving to divest; and (4) ba ...

DEADLINE: April 14, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/elastic-n-v-loss-submission-form/? id=139428&from=3 CLASS PERIOD: May 31, 2024 to August 29, 2024 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Elastic had implemented significant changes to its sales operations, particularly ...

CLASS PERIOD: March 13, 2023 to March 11, 2025 NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=139422& ...

NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. (NYSE: MRK). CONTACT US HERE: Shareholders who purchased shares of MRK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: February 3, 2022 to February 3, 2025 ALLEGATIONS: According to the complaint, defendants provided investors with ma ...

Core Viewpoint - Quantum Computing Inc. (QCI) is facing allegations of issuing materially false and misleading statements regarding its quantum computing technologies, relationships with NASA, and business dealings, which may have led to inflated stock prices during the class period from March 30, 2020, to January 15, 2025 [2]. Group 1: Allegations - Defendants allegedly overstated the capabilities of QCI's quantum computing technologies, products, and services [2]. - The nature and scope of QCI's relationship with NASA, including contracts and subcontracts, were also overstated [2]. - Claims regarding QCI's progress in developing a thin film lithium niobate (TFLN) foundry and related orders for TFLN chips were allegedly exaggerated [2]. - Business dealings with Quad M and millionways were classified as related party transactions, which were not disclosed [2]. - QCI's revenues were reportedly reliant on undisclosed related party transactions [2]. - The revelations of these issues are likely to have a significant negative impact on QCI's business and reputation [2]. - Public statements made by the defendants were materially false and misleading throughout the relevant period [2]. Group 2: Class Action Details - Shareholders who purchased QUBT shares during the class period are encouraged to register for the class action by April 28, 2025 [3]. - Registration allows shareholders to receive updates through portfolio monitoring software regarding the case's status [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Skyworks Solutions, Inc. regarding a class action lawsuit due to alleged misleading statements about the company's expected revenue for fiscal year 2025, which led to a significant drop in stock price after disappointing financial results were announced [1]. Group 1: Allegations and Financial Impact - The allegations state that defendants provided investors with material information about Skyworks' expected revenue, expressing confidence in the company's ability to grow its mobile business and diversify its offerings [1]. - On February 5, 2025, Skyworks announced lower-than-expected revenue guidance for Q2 of fiscal year 2025, attributing this to an intensified competitive landscape [1]. - Following the announcement, Skyworks' stock price plummeted from $87.08 per share to $65.60 per share on February 6, 2025, marking a decline of over 24% in one day [1]. Group 2: Class Action Details - The class period for the lawsuit is defined as July 30, 2024, to February 5, 2025, and shareholders are encouraged to register for participation [2]. - The deadline for shareholders to seek lead plaintiff status is May 5, 2025, and there is no cost or obligation to participate in the case [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements or omissions that artificially inflated stock prices [3].

Core Viewpoint - Atkore Inc. is facing a class action lawsuit due to allegations of engaging in an anticompetitive price-fixing scheme that inflated the price of PVC Pipes, leading to significant financial benefits that were unsustainable [1] Summary by Sections Allegations - The complaint claims that Atkore issued materially false and misleading statements and failed to disclose its involvement in a price-fixing scheme for PVC Pipes [1] - The scheme allegedly resulted in artificially inflated prices, which were unsustainable and negatively impacted Atkore's business and operations once exposed [1] - As a result of the exposure, the price of PVC Pipes decreased substantially, contradicting the positive statements made by the company regarding its business prospects [1] Class Action Details - The class period for the lawsuit is from August 2, 2022, to February 3, 2025, and shareholders who purchased shares during this time are encouraged to register for participation [1][2] - The deadline for shareholders to seek lead plaintiff status is April 23, 2025, and there is no cost or obligation to participate in the case [2] Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3]